{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:42:52Z","timestamp":1791286972360,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Merial R&D"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.vaccine.2011.04.058","type":"journal-article","created":{"date-parts":[[2011,5,8]],"date-time":"2011-05-08T03:12:53Z","timestamp":1304824373000},"page":"4608-4612","source":"Crossref","is-referenced-by-count":43,"title":["Protection provided by a recombinant ALVAC\u00ae-WNV vaccine expressing the prM\/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain"],"prefix":"10.1016","volume":"29","author":[{"given":"J.M.","family":"Minke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Siger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Cupillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Powers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Bakonyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Boyum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Nowotny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.04.058_bib0005","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/viro.2002.1449","article-title":"Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States and the Middle East","volume":"298","author":"Lanciotti","year":"2002","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.vaccine.2011.04.058_bib0010","first-page":"348","article-title":"West Nile virus in Europe and Africa: still minor pathogen, or potential threat to public health?","volume":"99","author":"Couissinier-Paris","year":"2006","journal-title":"Bull Soc. Pathol."},{"issue":"4","key":"10.1016\/j.vaccine.2011.04.058_bib0015","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1051\/vetres:2004022","article-title":"West Nile virus infection in horses","volume":"35","author":"Castillo-Olivares","year":"2004","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2011.04.058_bib0020","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1126\/science.286.5448.2333","article-title":"Origin of the West Nile virus responsible for an outbreak of encephalitis in the north-eastern United States","volume":"286","author":"Lanciotti","year":"1999","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2011.04.058_bib0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/153036604773083004","article-title":"The epidemic of West Nile virus in the United States, 2002","volume":"4","author":"O\u2019Learly","year":"2004","journal-title":"Vector Borne Zoon Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2011.04.058_bib0030","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3201\/eid1204.051379","article-title":"Lineage 1 and 2 strains of encephalitic West Nile virus, central Europe","volume":"12","author":"Bakonyi","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2011.04.058_bib0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/vbz.2006.0586","article-title":"Clinical and pathological features of lineage 2 West Nile virus infections in birds of prey in Hungary","volume":"7","author":"Erdelyi","year":"2007","journal-title":"Vector Borne Zoon Dis"},{"issue":"34","key":"10.1016\/j.vaccine.2011.04.058_bib0040","doi-asserted-by":"crossref","DOI":"10.2807\/ese.15.34.19644-en","article-title":"Ongoing outbreak of West Nile virus infections in humans in Greece, July\u2013August 2010","volume":"15","author":"Papa","year":"2010","journal-title":"Euro Surveill"},{"issue":"6","key":"10.1016\/j.vaccine.2011.04.058_bib0045","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2746\/042516403775467180","article-title":"West Nile virus infection of thoroughbred horses in South Africa (2000\u20132001)","volume":"35","author":"Guthrie","year":"2003","journal-title":"Equine Vet J"},{"issue":"6","key":"10.1016\/j.vaccine.2011.04.058_bib0050","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3201\/eid1506.081515","article-title":"Lineage 2 West Nile Virus as cause of fatal neurological disease in horses, South Africa","volume":"15","author":"Venter","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2011.04.058_bib0055","first-page":"221","article-title":"Equine vaccine for West Nile virus","volume":"114","author":"Ng","year":"2003","journal-title":"Dev Biol"},{"key":"10.1016\/j.vaccine.2011.04.058_bib0060","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1086\/323395","article-title":"Induction of potent Th-1 type immune response from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999)","volume":"184","author":"Yang","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.04.058_bib0065","first-page":"221","article-title":"Recombinant canarypoxvirus vaccine carrying the prM\/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge","volume":"18","author":"Minke","year":"2004","journal-title":"Arch Virol [suppl]"},{"key":"10.1016\/j.vaccine.2011.04.058_bib0070","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2746\/042516407X217416","article-title":"Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model","volume":"39","author":"Long","year":"2007","journal-title":"Equine Vet J"},{"issue":"11","key":"10.1016\/j.vaccine.2011.04.058_bib0075","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2460\/ajvr.2004.65.1459","article-title":"Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to a natural challenge with West Nile virus-infected mosquitoes in horses","volume":"65","author":"Siger","year":"2004","journal-title":"Am J Vet Res"},{"issue":"3","key":"10.1016\/j.vaccine.2011.04.058_bib0080","first-page":"249","article-title":"Evaluation of the efficacy provided by a recombinant canarypox-vectored equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses","volume":"7","author":"Siger","year":"2006","journal-title":"Vet Therap"},{"issue":"4","key":"10.1016\/j.vaccine.2011.04.058_bib0085","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3201\/eid0804.010239","article-title":"Experimental infection of horses with West Nile virus","volume":"8","author":"Bunning","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2011.04.058_bib0090","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1749-6632.2001.tb02690.x","article-title":"West Nile in the Mediterranean basin: 1950\u20132000","volume":"951","author":"Murgue","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2011.04.058_bib0095","article-title":"Equine encephalomyelitis outbreak caused by a genetic lineage 2 West Nile virus in Hungary","volume":"179","author":"Kutasi","year":"2009","journal-title":"AAEP Proceedings 55"},{"key":"10.1016\/j.vaccine.2011.04.058_bib0100","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1128\/JVI.71.5.3391-3396.1997","article-title":"Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the haemagglutinin","volume":"71","author":"Kodihalli","year":"1997","journal-title":"J. Virol"},{"key":"10.1016\/j.vaccine.2011.04.058_bib0105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1051\/vetres:2006045","article-title":"Prevalence and effects of West Nile virus infection in vaccinated and unvaccinated horses in California","volume":"38","author":"Gardner","year":"2007","journal-title":"Vet Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11006037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11006037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:15:48Z","timestamp":1592525748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11006037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":21,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0264410X11006037"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.04.058","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}